PIRS
Pieris Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ieris.com
- Employees(FY) 127
- ISIN US7207952026
Performance
-1.7%
1W
-16.39%
1M
-12.21%
3M
-40.89%
6M
-24.66%
YTD
-82.96%
1Y
Profile
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin based drug candidate, elarekibep used for the treatment of asthma; and PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis. The company also develops PRS-344/S09501 2that consists of a PD-L1-targeting antibody and 4-1BB-targeting Anticalin proteins. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.
Technical Analysis of PIRS 2024-05-10
Overview:
In analyzing the technical indicators for PIRS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...
Recent News & Updates
- 2024-05-17 02:52
- 2024-05-15 05:43
Pieris Pharmaceuticals: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-04-19 00:10
- 2024-03-26 20:00
- 2023-11-14 04:36
Pieris Pharmaceuticals: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-09-25 00:00
- 2023-08-24 00:32
- 2023-08-23 00:00
- 2023-08-16 20:00
- 2023-07-19 02:02
- 2023-07-18 20:40
Pieris (PIRS) Pursues Strategic Alternatives, Stock Rises(Yahoo Finance)
- 2023-07-18 01:59
Why Pieris Pharmaceuticals Shares Shooting Higher Today?(Yahoo Finance)
- 2023-07-17 21:15
- 2023-07-16 19:29
3 Doomed Biotech Stocks Destined for Disaster(Yahoo Finance)
- 2023-06-22 22:50
- 2023-06-20 19:00
- 2023-06-10 22:28
- 2023-06-02 04:30
- 2023-05-21 20:00
- 2023-05-20 20:00
- 2023-05-14 18:07
- 2023-05-11 01:41
- 2023-05-09 20:15
- 2023-05-09 19:00
- 2023-05-04 18:41
- 2023-05-03 20:00
- 2023-05-02 04:30
- 2023-04-16 20:00
- 2023-04-01 00:47
- 2023-03-30 18:10
Page 1 of 4
previousnext